how to grow a vegetable

Suramin is a 100-year-old drug developed to treat African sleeping sickness. It is not approved for any therapeutic use in the U.S. However, a small clinical trial at UC San Diego School of Medicine found that a single intravenous dose of suramin produced measurable, but transient, improvements in five boys with autism spectrum disorder (ASD). More broadly, the trial findings support the “cell danger response theory,” which posits that autism is driven by metabolic dysfunction — and thus treatable. Larger, longer clinical trials are needed to assess suramin as an ASD treatment. In this video we hear from lead researcher Robert Naviaux, MD, PhD, and the mothers of two boys who received suramin in the trial. For more, visit http://health.ucsd.edu/suramin

UC San Diego Health Sciences encompasses UC San Diego Health, the region's only academic health system, UC San Diego School of Medicine, one of the nation's top research-intensive medical schools, and Skaggs School of Pharmacy and Pharmaceutical Sciences, Southern California's first public school of pharmacy.

Vice Chancellor of Health Sciences David Brenner, MD, describes our innovate approach to medical and graduate education and how it’s informed by leading-edge research and collaboration. For more information, visit http://vchs.ucsd.edu.

In celebration of Women’s History month we are featuring a few of the women making history right now in cancer research and in cancer therapy. In this final video we hear from María Elena Martínez, PhD, associate director for population sciences, disparities and community engagement at Moores Cancer Center at UC San Diego Health. Her research aims to close an inequity gap in cancer treatment among various communities including racial and ethnic groups and rural populations.